Frazier Life Sciences Management’s Braveheart Bio BRVE Stock Holding History
Bought
Maintained
Sold
Other funds holding BRVE
Frazier Life Sciences Management's BRVE Position: Q3 2026 in Review
Frazier Life Sciences Management opened a new position in Braveheart Bio (BRVE) in Q3 2026: 5,267,321 shares worth $106M. The stake represents 2.64% of the portfolio and ranks #11 among its holdings.
64 funds tracked by Wall St. Rank hold BRVE as of Q3 2026.
- Frazier Life Sciences Management held 5,267,321 shares of Braveheart Bio worth $106M as of Q3 2026.
- Braveheart Bio was a new Frazier Life Sciences Management position in Q3 2026.
- Braveheart Bio made up 2.64% of Frazier Life Sciences Management's portfolio in Q3 2026, its #11 holding.
- 64 funds tracked by Wall St. Rank held Braveheart Bio as of Q3 2026.
Based on Frazier Life Sciences Management's 13F filing for Q3 2026, filed 16 Nov 2026.